bpc 157 human clinical trial evidence review safety Peptide BPC-157 Regeneration or Risk? A Narrative
Description
D., Capo, C., Mege, J.-L
And the culprit, more often than anyone wants to admit, is a reconstitution error made in the very first five minutes of handling the peptide
Both have excellent safety profiles with no known interactions
Many patients are surprised by how simple the process feels
If left untreated, the deficiency can cause severe neurologic problems and blood diseases
However, our study results do not support this hypothesis
